ZWBC yields 1000000.00% · ABBV yields 3.09%● Live data
📍 ZWBC pulled ahead of the other in Year 1
Combined, ZWBC + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ZWBC + ABBV for your $10,000?
GoldKey Corporation researches and develops, and sells networking and security products worldwide. It offers GoldKey Security Tokens that are used to securely authenticate, encrypt, and share sensitive information on computers, servers, and mobile devices, as well as in the cloud; and GoldKey secure portal, a rack-mount unit, which installs into a customer's data center to provide secure access protection to existing Web servers, as well as to create secure cloud storage on existing customer storage servers. The company also provides GoldKey master tokens that offer access to data encrypted by users in their organization; create and manage groups; reset GoldKey personalization data, such as the PIN; and duplicate GoldKeys. In addition, it provides GoldKey Vaults, an encrypted cloud storage service; GoldKey Mail, an encrypted cloud-based email system for businesses; and GoldKey Security Tokens, a solution to eliminate username and password-based authentication for two-factor authentication on air gapped computers and networks. Further, the company offers GoldKey Authentication, a secure sign in service; GoldKey Backup, an encrypted, off-site, and automated backup system that helps organizations in preventing loss of important files; and Data Center, a portal management service. It serves federal, state, and local government agencies; financial institutions, schools, and universities; and a range of security-conscious enterprises and individuals. The company was formerly known as WideBand Corporation and changed its name to GoldKey Corporation in December 2014. GoldKey Corporation is based in Gallatin, Missouri.
Full ZWBC Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.